ROUTINE USE OF CEREBRAL EMBOLIC PROTECTION DEVICE DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: WHAT DOES THE DATA SUPPORT? AN UPDATED META-ANALYSIS

Authors

Anne Cahill MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

3-2023

Volume

81

Issue

8

Published In/Presented At

doi/10.1016/S0735-1097%2823%2901263-9

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article